France· FR:68211089
FUNGIZONE NOURRISSONS ET ENFANTS 10 %, suspension buvable
A medicinal product containing amphotéricine b, registered in France by CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- AMPHOTÉRICINE B
- Manufacturer
- CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009346242231 flacon(s) en verre brun de 40 ml avec adaptateur avec seringue doseuse pour administration oraleEUR 4.85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amphotéricine b in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAbelcet 100mg/20ml concentrate for dispersion for infusion vialsTeva UK Ltd
- FinlandAbelcetTeva Pharma B.V.
- SwitzerlandAmbisome
- United StatesAmBisomeAstellas Pharma US, Inc.
- CzechiaABELCET LIPID COMPLEXTeva Pharmaceuticals CR, s.r.o., Praha
- PolandAbelcetTeva Pharmaceuticals Polska Sp. z o.o.
- GermanyAmbisome LiposomalGilead Sciences Gmbh
- NetherlandsAmBisome liposomale amfotericine B 50 mg, poeder voor dispersie voor infusieGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Ambisome Liposomal, Ampho-Moronal
- Belgium · Ambisome Liposomales, Amfotericine B Liposomaal Tillomed
- Bulgaria · Амфотерицин B Липозомал Тиломед
- Cyprus · Ambisome Liposomal, Amphotericin B Liposomal Tillomed
- Czechia · Abelcet Lipid Complex, Amfotericin B Liposomal Tillomed
- Germany · Ambisome Liposomal, Ampho-Moronal
- Denmark · Ambisome Liposomal
- Estonia · Amphotericin B Liposomal Tillomed
- Spain · Abelcet Complejo Lipídico, Ambisome Liposomal
- Finland · Ambisome Liposomal, Fungizone
- United Kingdom (Northern Ireland) · Amphotericin B Liposomal Gilead, Amphotericin B Liposomal Sun Pharma
- Greece · Ambisome Liposomal
- Hungary · Abelcet, Ambisome Liposzómás
- Ireland · Ambisome liposomal, Amphotericin B Liposomal Tillomed
- Iceland · Ambisome Liposomal
- Italy · Ambisome Liposomiale, Fungizone
- Luxembourg · Abelcet Lipid Complex, Ambisome Liposomales
- Latvia · Ambisome liposomāls, Amphotericin B Tillomed
- Malta · Ambisome Liposomal
- Netherlands · Ambisome liposomale, Amfotericine B Liposomaal Tillomed
- Norway · Ambisome Liposomal
- Poland · Abelcet, Ambisome Liposomal
- Portugal · Abelcet, Ambisome Lipossomal
- Romania · Ambisome liposomal, Amfotericină B Lipozomală Tillomed
- Sweden · Ambisome Liposomal, Amphotericin B Liposomal Tillomed
- Slovenia · Ambisome Liposomal, Amfotericin B Liposomal Tillomed
- Slovakia · Abelcet Lipid Complex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/61599884-9a84-4f1d-9395-86f335acf870 GET /v1/drugs/61599884-9a84-4f1d-9395-86f335acf870?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68211089",
"date_amm": "1998-11-23",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "AMPHOTÉRICINE B",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "suspension buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about amphotéricine b.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.